Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy

Background Natalizumab is an effective treatment for relapsing multiple sclerosis. Return of disease activity upon natalizumab discontinuance creates the need for follow-up therapeutic strategies. Objective To assess the efficacy of teriflunomide following natalizumab discontinuance in relapsing mul...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Stanley L Cohan, Keith Edwards, Lindsay Lucas, Tiffany Gervasi-Follmar, Judy O’Connor, Jessica Siuta, Vineetha Kamath, Lore Garten, Chiayi Chen, James Thomas, Kyle Smoot, Kiren Kresa-Reahl, Kateri J Spinelli
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2019-01-01
coleção:	Multiple Sclerosis Journal - Experimental, Translational and Clinical
Acesso em linha:	https://doi.org/10.1177/2055217318824618
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!